Recommendations for the Use of Prolonged‐Release Fampridine in Patients with Multiple Sclerosis (MS)

Prolonged‐release fampridine (fampridine PR) is a potassium channel blocker that improves conductivity of signal on demyelinated axons in central nervous system. Fampridine PR has been approved to improve speed of walking in patients with multiple sclerosis. This statement provides a brief summary o...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:CNS Neurosci Ther
Main Authors: Preiningerova, Jana Lizrova, Baumhackl, Ulf, Csepany, Tunde, Czaplinski, Adam, Deisenhammer, Florian, Derfuss, Tobias, Fabjan, Tanja H., Fazekas, Franz, Fuchs, Siegrid, Havrdova, Eva, Ledinek, Alenka Horvath, Illes, Zsolt, Jazbec, Sasa Sega, Klimova, Eleonora, Komoly, Samuel, Kurca, Egon, Linnebank, Michael, Lisy, Lubomir, Mares, Jan, Prochazkova, Lubica, Csilla, Rozsa, Szilasiova, Jarmila, Stourac, Pavel, Talab, Radomir, Turcani, Peter, Vachova, Marta, Vecsei, Laszlo, Vodusek, David, Zapletalova, Olga, Berger, Thomas
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley and Sons Inc. 2013
נושאים:
Clinical Guidelines
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493348/
https://ncbi.nlm.nih.gov/pubmed/23607697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12101
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים